These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. Sang TT; Guo CJ; Guo DD; Wang XY Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(16):3235-3242. PubMed ID: 30200724 [TBL] [Abstract][Full Text] [Related]
5. Obesity-Related Digestive Diseases and Their Pathophysiology. Nam SY Gut Liver; 2017 May; 11(3):323-334. PubMed ID: 27890867 [TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of obesity and related vascular diseases. Winter Y; Sankowski R; Back T Vitam Horm; 2013; 91():29-48. PubMed ID: 23374711 [TBL] [Abstract][Full Text] [Related]
7. [Criteria of obesity and obesity disease in Japan]. Chin R; Miyazaki S Nihon Rinsho; 2009 Feb; 67(2):297-300. PubMed ID: 19202902 [TBL] [Abstract][Full Text] [Related]
8. Obesity Paradox in the Course of Cerebrovascular Diseases. Brzecka A; Ejma M Adv Clin Exp Med; 2015; 24(3):379-83. PubMed ID: 26467124 [TBL] [Abstract][Full Text] [Related]
9. The effects of obesity on doctor-diagnosed chronic diseases in Africa: empirical results from Senegal and South Africa. Asfaw A J Public Health Policy; 2006; 27(3):250-64. PubMed ID: 17042123 [TBL] [Abstract][Full Text] [Related]
10. Obesity and the "obesity paradox" in cardiovascular diseases. Lavie CJ; Milani RV; Ventura HO Clin Pharmacol Ther; 2011 Jul; 90(1):23-5. PubMed ID: 21691270 [TBL] [Abstract][Full Text] [Related]
11. CD4 Zhao Y; Lin L; Li J; Xiao Z; Chen B; Wan L; Li M; Wu X; Hin Cho C; Shen J Cell Immunol; 2018 Oct; 332():1-6. PubMed ID: 30146083 [TBL] [Abstract][Full Text] [Related]
12. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study. Lu J; Bi Y; Wang T; Wang W; Mu Y; Zhao J; Liu C; Chen L; Shi L; Li Q; Wan Q; Wu S; Qin G; Yang T; Yan L; Liu Y; Wang G; Luo Z; Tang X; Chen G; Huo Y; Gao Z; Su Q; Ye Z; Wang Y; Deng H; Yu X; Shen F; Chen L; Zhao L; Dai M; Xu M; Xu Y; Chen Y; Lai S; Ning G Int J Cardiol; 2014 Mar; 172(2):388-94. PubMed ID: 24502884 [TBL] [Abstract][Full Text] [Related]
13. Reduced Lean Body Mass and Cardiometabolic Diseases in Adult Males with Overweight and Obesity: A Pilot Study. Khazem S; Itani L; Kreidieh D; El Masri D; Tannir H; Citarella R; El Ghoch M Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563167 [TBL] [Abstract][Full Text] [Related]
14. [MiRNAs in the diagnosis of cardiovascular diseases associated with type 2 diabetes mellitus and obesity]. Shvangiradze TA; Bondarenko IZ; Troshina EA; Shestakova MV Ter Arkh; 2016; 88(10):87-92. PubMed ID: 28635856 [TBL] [Abstract][Full Text] [Related]
15. [Estimates and trends of obesity prevalence through mortality rates associated of chronic diseases in Mexico]. Villa AR; Escobedo MH; Méndez-Sánchez N Gac Med Mex; 2004; 140 Suppl 2():S21-5. PubMed ID: 15641468 [TBL] [Abstract][Full Text] [Related]
16. [Obesity is a risk factor for eye diseases]. Habot-Wilner Z; Belkin M Harefuah; 2005 Nov; 144(11):805-9, 821. PubMed ID: 16358658 [TBL] [Abstract][Full Text] [Related]
17. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases. Matsuda M; Shimomura I Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768 [TBL] [Abstract][Full Text] [Related]
18. A review of the economic analysis of obesity. Hughes D; McGuire A Br Med Bull; 1997; 53(2):253-63. PubMed ID: 9246835 [TBL] [Abstract][Full Text] [Related]
19. [An overview of diseases inducing secondary obesity]. Tsuchiya T; Mori M Nihon Rinsho; 2009 Feb; 67(2):357-61. PubMed ID: 19202912 [TBL] [Abstract][Full Text] [Related]
20. [Ayurveda for the treatment of obesity]. Korossy A; Blázovics A Orv Hetil; 2016 Aug; 157(34):1349-52. PubMed ID: 27546800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]